Stefanie A. Gauw

1.9k citations

22 papers · 1.3k indexed · h-index 15

Pulmonary and Respiratory Medicine top 5%
Physiology top 5%
Biomedical Engineering top 10%
Surgery top 10%
Internal Medicine top 2%

Co-authors: Klaus F. Rabe Elisabeth H. Bel Peter J. Sterk Robert Schot Peter Sterk Michael C. Mooij Pascal Pronk Menno Gaastra
Topics: Vector-borne infectious diseases (7 papers)Diagnosis and Treatment of Venous Diseases (7 papers)Asthma and respiratory diseases (7 papers)
Cited by: Internal Medicine Physiology Pulmonary and Respiratory Medicine
Journals: Journal of Allergy and Clinical Immunology European Respiratory Journal The Lancet Infectious Diseases
Partner nations: Netherlands Germany United Kingdom

In The Last Decade

Stefanie A. Gauw

21 papers receiving 1.2k citations

Peers

Countries citing papers authored by Stefanie A. Gauw

Since Specialization

Citations

This map shows the geographic impact of Stefanie A. Gauw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefanie A. Gauw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefanie A. Gauw more than expected).

Fields of papers citing papers by Stefanie A. Gauw

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefanie A. Gauw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefanie A. Gauw. The network helps show where Stefanie A. Gauw may publish in the future.

Co-authorship network of co-authors of Stefanie A. Gauw

This figure shows the co-authorship network connecting the top 25 collaborators of Stefanie A. Gauw. A scholar is included among the top collaborators of Stefanie A. Gauw based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefanie A. Gauw. Stefanie A. Gauw is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Evaluation and 1-year follow-up of patients presenting at a Lyme borreliosis expertise centre: a prospective cohort study with validated questionnaires 2024 ·European Journal of Clinical Microbiology & Infectious Diseases ·(unknown),(unknown),Stefanie A. Gauw,(unknown),Hedwig D. Vrijmoeth,(unknown),(unknown),(unknown),A Wong,Cees C. van den Wijngaard,Leo A. B. Joosten,Joppe W. Hovius,Bart Jan Kullberg	1
2	Determinants of persistent symptoms after treatment for Lyme borreliosis: a prospective observational cohort study 2023 ·EBioMedicine ·Hedwig D. Vrijmoeth,(unknown),Margriet Harms,(unknown),(unknown),(unknown),Stefanie A. Gauw,Tizza P. Zomer,(unknown),José A. Ferreira,Hein Sprong,Kristin Kremer,Hans Knoop,Leo A. B. Joosten,Bart Jan Kullberg,Joppe W. Hovius,Cees C. van den Wijngaard	16
3	Diagnostic parameters of cellular tests for Lyme borreliosis in Europe (VICTORY study): a case-control study 2022 ·The Lancet Infectious Diseases ·(unknown),(unknown),Stefanie A. Gauw,Hedwig D. Vrijmoeth,(unknown),(unknown),Călin D. Popa,(unknown),Mariska Leeflang,Kristin Kremer,Cees C. van den Wijngaard,Bart Jan Kullberg,Leo A. B. Joosten,Joppe W. Hovius	4
4	Prevalence of persistent symptoms after treatment for lyme borreliosis: A prospective observational cohort study 2021 ·The Lancet Regional Health - Europe ·(unknown),Hedwig D. Vrijmoeth,Margriet Harms,(unknown),Hans Knoop,Stefanie A. Gauw,Tizza P. Zomer,Albert Wong,Ingrid Friesema,(unknown),Leo A. B. Joosten,Joppe W. Hovius,Bart Jan Kullberg,Cees C. van den Wijngaard	51
5	Ticking on Pandora’s box: a prospective case-control study into ‘other’ tick-borne diseases 2021 ·BMC Infectious Diseases ·Dieuwertje Hoornstra,(unknown),Stefanie A. Gauw,Alex Wagemakers,Tal Azagi,Kristin Kremer,Hein Sprong,Cees C. van den Wijngaard,Joppe W. Hovius	6
6	Validation of cellular tests for Lyme borreliosis (VICTORY) study 2019 ·BMC Infectious Diseases ·(unknown),(unknown),Stefanie A. Gauw,Leo A. B. Joosten,Bart Jan Kullberg,Cees C. van den Wijngaard,Joppe W. Hovius	13
7	Prevalence and determinants of persistent symptoms after treatment for Lyme borreliosis: study protocol for an observational, prospective cohort study (LymeProspect) 2019 ·BMC Infectious Diseases ·Hedwig D. Vrijmoeth,(unknown),Margriet Harms,Tizza P. Zomer,Stefanie A. Gauw,(unknown),Kristin Kremer,Hein Sprong,Hans Knoop,(unknown),(unknown),Leo A. B. Joosten,Bart Jan Kullberg,Joppe W. Hovius,Cees C. van den Wijngaard	20
8	Prospective comparative cohort study evaluating incompetent great saphenous vein closure using radiofrequency-powered segmental ablation or 1470-nm endovenous laser ablation with radial-tip fibers (Varico 2 study) 2017 ·Journal of Vascular Surgery Venous and Lymphatic Disorders ·James A. Lawson,Stefanie A. Gauw,(unknown),Pascal Pronk,Menno Gaastra,Marco J.D. Tangelder,Michael C. Mooij	55
9	Five-year follow-up of a randomized, controlled trial comparing saphenofemoral ligation and stripping of the great saphenous vein with endovenous laser ablation (980 nm) using local tumescent anesthesia 2015 ·Journal of Vascular Surgery ·Stefanie A. Gauw,James A. Lawson,C.J. van Vlijmen-van Keulen,Pascal Pronk,Menno Gaastra,Michael C. Mooij	77
10	Sapheon: the solution? 2013 ·Phlebology The Journal of Venous Disease ·James Lawson,Stefanie A. Gauw,(unknown),Pascal Pronk,Menno Gaastra,Michael C. Mooij,C.H.A. Wittens	22
11	Autologous skin substitute for hard‐to‐heal ulcers: Retrospective analysis on safety, applicability, and efficacy in an outpatient and hospitalized setting 2013 ·Wound Repair and Regeneration ·(unknown),(unknown),E. M. de Boer,Catherine van Montfrans,(unknown),Michael C. Mooij,Stefanie A. Gauw,(unknown),(unknown),(unknown),Joop Kuik,Taco Waaijman,Rik J. Scheper,Susan Gibbs	15
12	Detection of varicose vein recurrence by duplex ultrasound: intra- and interobserver reproducibility 2012 ·Phlebology The Journal of Venous Disease ·Stefanie A. Gauw,Pascal Pronk,Michael C. Mooij,Menno Gaastra,James A. Lawson,C.J. van Vlijmen-van Keulen	1
13	Randomised Controlled Trial Comparing Sapheno-Femoral Ligation and Stripping of the Great Saphenous Vein with Endovenous Laser Ablation (980 nm) Using Local Tumescent Anaesthesia: One Year Results 2010 ·European Journal of Vascular and Endovascular Surgery ·Pascal Pronk,Stefanie A. Gauw,Michael C. Mooij,Menno Gaastra,James A. Lawson,(unknown),C.J. van Vlijmen-van Keulen	102
14	Randomised Controlled Trial Comparing Sapheno-Femoral Ligation and Stripping of the Great Saphenous Vein with Endovenous Laser Ablation (980 nm) Using Local Tumescent Anaesthesia: One Year Results 2010 ·Journal of Vascular Surgery ·Pascal Pronk,Stefanie A. Gauw,Michael C. Mooij,Menno Gaastra,James A. Lawson,C.J. van Vlijmen-van Keulen	9
15	Comparison of exhaled breath condensate pH using two commercially available devices in healthy controls, asthma and COPD patients 2009 ·Respiratory Research ·Andreas Rembert Koczulla,Silvano Dragonieri,Robert Schot,Robert Bals,Stefanie A. Gauw,Claus Vogelmeier,Klaus F. Rabe,Peter Sterk,Pieter S. Hiemstra	48
16	Exhaled nitric oxide predicts lung function decline in difficult-to-treat asthma 2008 ·European Respiratory Journal ·Ilonka H. van Veen,Anneke Ten Brinke,Peter Sterk,Jacob K. Sont,Stefanie A. Gauw,Klaus F. Rabe,Elisabeth H. Bel	94
17	Reduction in sputum neutrophil and eosinophil numbers by the PDE4 inhibitor roflumilast in patients with COPD 2007 ·Thorax ·Diana C. Grootendorst,Stefanie A. Gauw,Renate M. Verhoosel,Peter J. Sterk,Jeannette J. Hospers,Dirk Bredenbröker,T.D. Bethke,Pieter S. Hiemstra,Klaus F. Rabe	225
18	Alveolar nitric oxideversusmeasures of peripheral airway dysfunction in severe asthma 2006 ·European Respiratory Journal ·Ilonka H. van Veen,Peter Sterk,Robert Schot,Stefanie A. Gauw,Klaus F. Rabe,Elisabeth H. Bel	110
19	Efficacy of the novel phosphodiesterase-4 inhibitor BAY 19-8004 on lung function and airway inflammation in asthma and chronic obstructive pulmonary disease (COPD) 2003 ·Pulmonary Pharmacology & Therapeutics ·Diana C. Grootendorst,Stefanie A. Gauw,(unknown),Peter Sterk,P.S. Hiemstra,Klaus F. Rabe	25
20	Does a single dose of the phosphodiesterase 4 inhibitor, cilomilast (15mg), induce bronchodilation in patients with chronic obstructive pulmonary disease? 2003 ·Pulmonary Pharmacology & Therapeutics ·Diana C. Grootendorst,Stefanie A. Gauw,Robert A. Baan,John A. Kelly,R.D. Murdoch,Peter Sterk,Klaus F. Rabe	48

About Stefanie A. Gauw

Stefanie A. Gauw is a scholar working on Internal Medicine, Parasitology and Emergency Medical Services, having authored 22 papers that have together received 1.3k indexed citations. Recurring topics across this work include Vector-borne infectious diseases (7 papers), Diagnosis and Treatment of Venous Diseases (7 papers) and Asthma and respiratory diseases (7 papers). The work is most often cited by research in Internal Medicine (244 citations), Physiology (519 citations) and Pulmonary and Respiratory Medicine (539 citations). Stefanie A. Gauw has collaborated with scholars based in Netherlands, Germany and United Kingdom. Frequent co-authors include Klaus F. Rabe, Elisabeth H. Bel, Peter J. Sterk, Robert Schot, Peter Sterk, Michael C. Mooij, Pascal Pronk, Menno Gaastra, James A. Lawson and Diana C. Grootendorst. Their work appears in journals such as Journal of Allergy and Clinical Immunology, European Respiratory Journal and The Lancet Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact